- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03238222
Motivating Structured Walking Activity in Intermittent Claudication (MOSAIC)
A Brief Physiotherapist-led Behaviour Change Intervention to Facilitate Walking in Older People With Peripheral Arterial Disease: a Randomised Controlled Trial
Peripheral arterial disease can cause leg pain or discomfort (called intermittent claudication (IC)), which limits the ability to walk and carry out everyday activities. Lifestyle changes, like increasing walking, can lead to improvements, but can be a challenge to begin and then continue. The aim of this study is to investigate if a physiotherapist-led, behaviour change treatment effects walking in people with IC. The treatment is designed to build an understanding of IC and walking exercise and help individuals develop strategies to increase regular walking. The trial will recruit 192 adults (aged 50 years and over) with IC. All participants will visit King's College London or their local hospital to complete two short walking tests and answer questionnaires about their daily activities, beliefs about their symptoms and treatment, quality of life and the costs of having IC.
Participants will then be randomly assigned to receive either the new treatment or continue with their usual NHS care. The new treatment involves two 60-minute face-to-face sessions (at the participant's home or local hospital) and two 20-minute telephone calls with a physiotherapist who will discuss participants' understanding and beliefs about IC, walking and help participants to set goals and plans to increase walking over 12 weeks. Participants will be provided with a step counter (pedometer) and walking record.
After 12 weeks, all participants will attend a second appointment where they will repeat the walking tests and fill out another set of questionnaires. A final set of questionnaires will be completed by all participants after 6 months (by post or electronically). Some participants will be invited to provide feedback on their experience of the treatment and trial by telephone or a face-to-face interview with a researcher.
Studieoversigt
Status
Intervention / Behandling
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
London, Det Forenede Kongerige
- Rekruttering
- King's College Hospital NHS Foundation Trust
-
London, Det Forenede Kongerige
- Rekruttering
- Royal Free London NHS Foundation Trust
-
London, Det Forenede Kongerige
- Rekruttering
- Guy's & St Thomas NHS Foundation Trust
-
London, Det Forenede Kongerige
- Rekruttering
- Lewisham and Greenwich NHS Trust (GSTT PIC site)
-
London, Det Forenede Kongerige
- Rekruttering
- St George's University Hospital NHS Foundation Trust
-
London, Det Forenede Kongerige
- Rekruttering
- The Royal London Hospital, Barts Heatth NHS Trust
-
-
Kent
-
Dartford, Kent, Det Forenede Kongerige
- Rekruttering
- Dartford and Gravesham NHS Trust (GSTT PIC site)
-
Maidstone, Kent, Det Forenede Kongerige
- Rekruttering
- Maidstone and Tunbridge Wells NHS Trust (GSTT PIC site)
-
-
Surrey
-
Ashford, Surrey, Det Forenede Kongerige
- Rekruttering
- Ashford & St Peter's NHS Foundation Trust
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- ≥50 years of age;
- established PAD (Ankle Brachial Pressure Index ≤0.90 and/or radiographic evidence or clinician reported diagnosis) and IC (presence of symptoms reported on the San Diego Claudication Questionnaire)
- able to participate in MOSAIC
- able and willing to provide informed consent
Exclusion Criteria:
- Unstable IC (self-reported change in symptoms during previous 3 months)
- walking >90 minutes/week (reported on Brief International Physical Activity Questionnaire
- contraindications to walking exercise (e.g., unstable angina) confirmed by their vascular specialist
- have completed any prescribed supervised exercise sessions in the previous 6 months or been offered prescribed exercise sessions in the next 6 months.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: MOSAIC Treatment
MOSAIC treatment plus Usual NHS Care.
MOSAIC treatment comprises 2 x 60-minute individual face-to-face consultations (weeks 1 & 2) and 2 x 20-minute follow-up telephone calls (weeks 6 & 12) with a trained physiotherapist.
|
MOSAIC comprises 2 x 60-minute individual face-to-face consultations (weeks 1 & 2) and 2 x 20-minute follow-up telephone calls (weeks 6 & 12) delivered at a convenient time and location of participant's choice (local NHS Trust or participant's home).
All sessions are delivered by a trained Band 6/7 physiotherapist.
All participants randomized to receive MOSAIC will be provided with a pedometer and a patient manual which will include information on intermittent claudication, risk factors, walking guidelines, goal setting, problem solving and action planning worksheets and a walking diary.
Andre navne:
|
|
Ingen indgriben: Usual Care Comparison
Usual NHS care for people with intermittent claudication typically consists of an initial assessment, drug therapy and simple advice to walk provided by a vascular specialist and delivered in the vascular outpatient clinic.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
6 Minute Walk Distance
Tidsramme: 3 months
|
6 Minute Walking Distance (in metres) measured during a self-paced, standardised 6 Minute Walk Test conducted around a level, 100-foot circuit.
|
3 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
6 Minute Walk Distance (6MWD)
Tidsramme: Baseline and 3 months
|
6 Minute Walking Distance (in metres) measured during a self-paced, standardised 6 Minute Walk Test conducted around a level, 100-foot circuit.
|
Baseline and 3 months
|
|
Self-reported Maximum Walking Distance
Tidsramme: Baseline, 3 and 6 months
|
Single global item
|
Baseline, 3 and 6 months
|
|
Self-Reported Walking Ability
Tidsramme: Baseline, 3 and 6 months
|
Walking Estimated-Limitation Calculated by History (WELCH)
|
Baseline, 3 and 6 months
|
|
Activities of Daily Living
Tidsramme: Baseline, 3 and 6 months
|
Nottingham Extended Activities of Daily Living (NEADL)
|
Baseline, 3 and 6 months
|
|
Health-Related Quality of Life
Tidsramme: Baseline, 3 and 6 months
|
Vascular Quality of Life Questionnaire-6 (VascuQol-6)
|
Baseline, 3 and 6 months
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Treatment Cognitions
Tidsramme: Baseline, 3 and 6 months
|
Theory of Planned Behaviour Questionnaire
|
Baseline, 3 and 6 months
|
|
Illness Cognitions
Tidsramme: Baseline, 3 and 6 months
|
Brief Illness Perceptions Questionnaire (BIPQ)
|
Baseline, 3 and 6 months
|
|
Walking Adherence
Tidsramme: Baseline, 3 and 6 months
|
Exercise Adherence Rating Scale
|
Baseline, 3 and 6 months
|
|
Resource Use
Tidsramme: Baseline, 3 and 6 months
|
Client Service Receipt Inventory
|
Baseline, 3 and 6 months
|
|
Health Related Quality of Life
Tidsramme: Baseline, 3 and 6 months
|
Euroqol- 5D-5L
|
Baseline, 3 and 6 months
|
|
Pain Free Walking Ability
Tidsramme: Baseline and 3 months
|
Patient-reported pain free walking time (seconds) and distance (metres) during the 6 Minute Walk Test
|
Baseline and 3 months
|
|
Maximal Walking Ability
Tidsramme: Baseline and 3 months
|
The maximum time (seconds) and distance (metres) walked before stopping during a 6 Minute Walk Test
|
Baseline and 3 months
|
Samarbejdspartnere og efterforskere
Efterforskere
- Ledende efterforsker: Sanjay Patel, Guy's and St Thomas' NHS Foundation Trust
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 17/LO/0568
- R477/0516 (Andet bevillings-/finansieringsnummer: Dunhill Medical Trust)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Perifer arteriel sygdom
-
Mayo ClinicTilmelding efter invitationAnatomi af GSV for Rescue Peripheral IV AccessForenede Stater
-
Universitaire Ziekenhuizen KU LeuvenUniversity of Pittsburgh; Sheba Medical Center; Mount Sinai Hospital, Canada og andre samarbejdspartnereRekrutteringTwin Reversal Arterial Perfusion SyndromeSpanien, Tyskland, Israel, Belgien, Holland, Canada, Forenede Stater, Østrig, Frankrig, Italien, Det Forenede Kongerige
-
Nanfang Hospital, Southern Medical UniversityRekrutteringBevacizumab | Hepatecellular carcinoma | QL1706 | RALOX-HAIC (Hepatic Arterial Infusion Chemoterapi med Raltitrexed og Oxaliplatin) | Type VP3/4 Portalvene Tumor Trombose | Iparomlimab og Tuvonralimab-injektionKina
-
University of MiamiAktiv, ikke rekrutterendeTvilling til tvilling transfusionssyndrom | Tvilling; Komplicerer graviditet | Twin Reversal Arterial Perfusion Syndrome | Monokorionisk diamniotisk placenta | Monokorial monoamniotisk placentaForenede Stater
-
Boston Children's HospitalRekrutteringGraviditetsrelateret | Moderlige; Procedure | Fostertilstande | Twin Monochorionic Monoamniotic Placenta | Tvilling til tvilling transfusionssyndrom | Twin Reversal Arterial Perfusion Syndrome | Vasa Previa | In utero-procedure, der påvirker foster eller nyfødte | Chorion; Abnorm | ChorioangiomForenede Stater
Kliniske forsøg med MOSAIC
-
Medtronic Bakken Research CenterAfsluttetKoronararterie-bypass-transplantation | Udskiftning af aortaklapBelgien, Israel, Tyskland, Østrig, Italien
-
University Hospital Plymouth NHS TrustAfsluttetUdskiftning af hjerteklapDet Forenede Kongerige
-
Michigan State UniversityAfsluttetDepression | Intim partnervold | Posttraumatisk stresssymptomForenede Stater
-
Michigan State UniversityAfsluttetDepression | Post traumatisk stress syndrom | Intim partnervoldForenede Stater
-
Janssen Vaccines & Prevention B.V.AfsluttetSund og raskForenede Stater, Mexico, Spanien, Puerto Rico, Italien, Polen, Argentina, Brasilien, Peru
-
National Institute of Allergy and Infectious Diseases...HIV Vaccine Trials Network; IPPOX Foundation; Center for HIV/AIDS Vaccine...Trukket tilbage
-
Janssen Vaccines & Prevention B.V.AfsluttetSund og raskForenede Stater, Rwanda, Kenya
-
National Institute of Allergy and Infectious Diseases...HIV Vaccine Trials Network; IPPOX Foundation; CHAVI; MHRPAfsluttetHIV-infektionerForenede Stater, Schweiz